For this 2022 edition, Biofortis will be present during the Pharmabiotic Research Institute (PRI)’s annual conference in Lyon, France, 20/21 April 2022. Our CSO, Françoise Le Vacon will lead a session during the second day : “First in Human Clinical Trials”
Pharmabiotics Conference & Partnering brings together players from academia and industry to make Microbiome-based Drug Products a therapeutic reality. The scientific program is organised in such a way to reflect the R&D continuum, addressing each major phase of scientific advances, challenges and innovations across all stages of microbiome product development.
Don’t hesitate to contact Biofortis or to meet us at our booth!